Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating Hepatitis C Treatment in the Postpartum Setting: A Call for Practice Innovation.

Journal of midwifery & women's health·2026
Same author

Predicting Structural Properties of Cortical Bone by Combining Ultrasonic Attenuation and an Artificial Neural Network (ANN): 2-D FDTD Study.

Image Analysis and Recognition: International Conference, ICIAR ... : proceedings. ICIAR·2024
Same author

Risk of Severe Maternal Morbidity in Birthing People With Opioid Use Disorder.

Women's health issues : official publication of the Jacobs Institute of Women's Health·2023
Same author

Decreasing Decision-to-Incision Times for Unscheduled, Urgent Cesarean Deliveries.

Obstetrics and gynecology·2023
Same author

Development and testing of a decision aid to achieve shared decision-making for routine labor induction.

Birth (Berkeley, Calif.)·2023
Same author

Implementation of a pharmacological prophylaxis bundle to prevent obstetric-associated venous thromboembolism.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2022

Related Experiment Video

Updated: Nov 14, 2025

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.0K

Implementation of a Universal Screening Process for Substance Use in Pregnancy.

Micah Ulrich1, Elise Petersen Memmo, Alissa Cruz

  • 1Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts.

Obstetrics and Gynecology
|March 11, 2021
PubMed
Summary
This summary is machine-generated.

Implementing universal substance use screening in prenatal care is feasible, identifying at-risk patients. Sustaining documentation of brief interventions for positive screens requires further effort.

More Related Videos

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

451
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

86.9K

Related Experiment Videos

Last Updated: Nov 14, 2025

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.0K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

451
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

86.9K

Area of Science:

  • Obstetrics and Gynecology
  • Public Health
  • Healthcare Quality Improvement

Background:

  • Substance use during pregnancy poses significant risks to both mother and child.
  • Standardized screening processes are crucial for early identification and intervention in prenatal care settings.
  • Existing screening methods may not be universally applied in diverse clinical environments.

Purpose of the Study:

  • To implement and evaluate a standardized universal substance use screening process for prenatal patients.
  • To assess the feasibility and effectiveness of integrating the 5Ps screening tool and SBIRT model into routine prenatal care.
  • To measure the rates of screening completion, positive screens, and subsequent interventions.

Main Methods:

  • A quality-improvement framework utilizing process modeling and plan-do-study-act cycles was employed.
  • A modified 5Ps (Parents, Peers, Partner, Past, Present) screening tool was adapted for universal use.
  • The Screening, Brief Intervention, Referral to Treatment (SBIRT) model guided the intervention workflow.

Main Results:

  • A substance use screen was completed in 84% of 733 patient encounters over 19 months.
  • Screening rates exceeded the 90% goal in the final six months of data collection.
  • 20% of screened patients tested positive, with intervention documentation reaching 80% initially but declining to 50%.

Conclusions:

  • A sustainable and generalizable universal substance use screening process is achievable in large prenatal clinics.
  • The screening process successfully identified patients not previously known to be at risk.
  • Sustaining healthcare practitioner documentation of interventions for positive screens remains a challenge requiring further investigation.